<i>In Vitro</i>Evaluation of the Dual Pharmacological Action of Vitamin D<sub>3</sub>as Cardio-protectant and Anti-cancer Agent
The changes in cancer cell viability in Sim and Seq were not significantly different from that of DOX, suggesting no added benefit from adding vitamin D<sub>3</sub> to DOX-containing treatment regimens.
Authors
- Yesenia L. Franco (ORCID: https://orcid.org/0000-0003-1387-2601)
- Sihem Ait‐Oudhia
- Hardik Mody
Institutions
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- American Association of Colleges of Pharmacy (US)
- University of Florida (US)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-05-27
- DOI
- https://doi.org/10.21873/anticanres.17608
- Primary Topic
- Vitamin D Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00